logo-loader
RNS
Avingtrans PLC

Avingtrans PLC - Trading Update and Notice of Results

RNS Number : 5778R
Avingtrans PLC
07 July 2022
 

7 July 2022

Avingtrans Plc

("Avingtrans", the "Company", or the "Group")

Trading Update and Notice of Results

Avingtrans PLC (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors,  announces a trading update in respect of the financial year ended 31 May 2022.

The Board is pleased to report that the results for the year ended 31 May 2022 are expected to be in line with market expectations. The Group's year end net cash position was strong, standing at in excess of £16 million (excluding IFRS 16), following investments in the period in Magnetica, Adaptix and Transkem, compared to £23 million as at 31 May 2021. The Group's order and prospect pipeline also remains strong.

Hayward Tyler, Inc. has secured a contract extension for the continued development of next generation molten salt pumps, under the Advanced Reactor Demonstration Program, valued at US $1.1m. This recent contract extends the program value beyond $2.5 million since June 2021. In addition to the contract extension, Hayward Tyler, Inc. became the first US company to update its ASME "N" Certifications to include Section III, Division 5 equipment.  This section of the code allows for design, manufacture, and inspection of pumps and process equipment for advanced, high temperature nuclear reactors.  

Avingtrans partner company, Adaptix, has filed its 510(k) premarket notification with the US FDA -  allowing the company to begin marketing its Point-of-Care 3D orthopedic system in the United States.  Adaptix has developed novel technologies that allow affordable, low-dose 3D imaging at the Point-of-Care using Digital Tomosynthesis (DT), to provider quicker, more accurate diagnosis possibilities. This is a significant milestone for Adaptix and trailblazes the path for Magnetica.

The Company is also pleased to have received an award for 'Transaction of the Year', in relation to the disposal of Peter Brotherhood in 2021, at the annual Small Cap Awards ceremony 2022. The Company has been judged amongst the best companies and participants in the small and micro-cap community across thirteen categories recognising outstanding achievement. The award is welcome recognition of the Group's successful PIE strategy, which aims to maximise shareholder value over the long term.

Notice of Results

Avingtrans will publish its results for the twelve months ended 31 May 2022 on 28 September 2022. 

The management team will be hosting a presentation for analysts on the day of results - for more information please contact Zach Cohen at IFC Advisory on zach.cohen@investor-focus.co.uk

Steve McQuillan, CEO of Avingtrans, commented:

"We are very pleased with the performance of the Group, overcoming many challenges and working tirelessly to report results for the year ended 31 May 2022 in line with market expectations. The Company has entered the new financial year with continued momentum, with strategic progress continuing and a robust pipeline of opportunites setting the foundations for solid growth for the coming year."

Enquiries:

Avingtrans plc

01354 692391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

Singer Capital Markets (Nominated Adviser and Broker)

02074 963000

Shaun Dobson

Alex Bond

Oliver Platts

Rachel Hayes

 

IFC Advisory (Financial PR)

020 3934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

 

About Avingtrans plc: 

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

Business units

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

Energy Steel, Inc - Rochester Hills, Michigan, USA

Energy Steel, part of the Engineered Pumps and Motors Division of Avingtrans plc, has been serving the nuclear power industry since 1982 with capabilities in equipment fabrication, material supply, precision machining, engineering, and repair services. Through strategic OEM partnerships, it also provides solutions for obsolete nuclear components and support for the most complex projects. 

Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast &explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above

Ormandy Group, Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units:

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments. 

Tecmag Inc, Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRFMATMTBMBRT
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

5 min read